Condition: Sarcopenia · Ageing Well · Sponsor: University of Greenwich
* Aim: to analyse the effects of microcurrent treatment alone, and combined with a resistance exercise programme, on muscle strength, body composition and physical functional capacity in middle-aged adults. * Methods * Randomised, balanced, double-blind parallel-group between-participants design. * Participants - non-regularly trained adults (people who do not engage regularly in physical sessions), aged 40 to 65 years old. * All participants will be invited to take part in a 6-week supervised resistance training programme that will be combined with microcurrent (MC) or sham (SH) intervention. The participants who do not accept to undergo the resistance training programme will integrate a non-exercise group involving a 6-week intervention period using the microcurrent (MC) or the sham (SH) device. The devices will be provided by Arc4Health (ARC Microtech Ltd, UK; https://arcmicrotech.com/arc4health/). The device Arc4Health has regulatory approval as a Class IIa medical device in the areas of pain management and tissue repair. The following will be analysed: 1. Microcurrent alone (MC) 2. Microcurrent with exercise (MC + RT) 3. Sham alone (SH) 4. Sham with exercise (SH + RT) * The participants who agree to take part in the training programme will have 2 sessions a week for a period of 6 weeks. The training programme involves elastic bands and is designed to increase strength and muscle mass. * Measurements of body composition (via plethysmography BodPod), streng…
This description comes directly from the study's public registry record.
Fernando Naclerio, PhD · 020 8331 8441 · f.j.naclerio@greenwich.ac.uk
Stefan Kolimechkov, PhD · 07999578700 · dr.stefan.kolimechkov@gmail.com
Always discuss trial participation with your own doctor first.
| School of Human Sciences, University of Greenwich, Avery Hill Campus, Sparrows Farm | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05567237